Back to Search Start Over

Acute and repeated impact of sweeteners and sweetness enhancers in solid and semi-solid foods on appetite : protocol for a multicentre, cross-over, RCT in people with overweight/obesity - the SWEET Project

Authors :
Gibbons, Catherine
O'Hara, Beverley
O'Connor, Dominic
Hardman, Charlotte
Wilton, Moon
Harrold, Joanne A.
Almiron-Roig, Eva
Navas-Carretero, Santiago
Hodgkins, Charo E.
Nazare, Julie Anne
Alligier, Maud
Martínez, Jose Alfredo
Scott, Corey
Kjølbæk, Louise
Normand, Mie
Rannou, Cécile
Blaak, Ellen E.
Feskens, Edith
Moshoyiannis, Hariklia
Raben, Anne
Halford, Jason C.G.
Beaulieu, Kristine
Finlayson, Graham
Gibbons, Catherine
O'Hara, Beverley
O'Connor, Dominic
Hardman, Charlotte
Wilton, Moon
Harrold, Joanne A.
Almiron-Roig, Eva
Navas-Carretero, Santiago
Hodgkins, Charo E.
Nazare, Julie Anne
Alligier, Maud
Martínez, Jose Alfredo
Scott, Corey
Kjølbæk, Louise
Normand, Mie
Rannou, Cécile
Blaak, Ellen E.
Feskens, Edith
Moshoyiannis, Hariklia
Raben, Anne
Halford, Jason C.G.
Beaulieu, Kristine
Finlayson, Graham
Source :
ISSN: 2044-6055
Publication Year :
2022

Abstract

INTRODUCTION: Intake of free sugars in European countries is high and attempts to reduce sugar intake have been mostly ineffective. Non-nutritive sweeteners and sweetness enhancers (S&SEs) can maintain sweet taste in the absence of energy, but little is known about the impact of acute and repeated consumption of S&SE in foods on appetite. This study aims to evaluate the effect of acute and repeated consumption of two individual S&SEs and two S&SE blends in semisolid and solid foods on appetite and related behavioural, metabolic and health outcomes. METHODS AND ANALYSIS: A work package of the SWEET Project; this study consists of five double-blind randomised cross-over trials which will be carried out at five sites across four European countries, aiming to have n=213. Five food matrices will be tested across three formulations (sucrose-sweetened control vs two reformulated products with S&SE blends and no added sugar). Participants (body mass index 25-35 kg/m2; aged 18-60 years) will consume each formulation for 14 days. The primary endpoint is composite appetite score (hunger, inverse of fullness, desire to eat and prospective food consumption) over a 3-hour postprandial incremental area under the curve during clinical investigation days on days 1 and 14. ETHICS AND DISSEMINATION: The trial has been approved by national ethical committees and will be conducted in accordance with the Declaration of Helsinki. Results will be published in international peer-reviewed open-access scientific journals. Research data from the trial will be deposited in an open-access online research data archive. TRIAL REGISTRATION NUMBER: NCT04633681.

Details

Database :
OAIster
Journal :
ISSN: 2044-6055
Notes :
application/pdf, BMJ Open 12 (2022) 12, ISSN: 2044-6055, ISSN: 2044-6055, English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1376683250
Document Type :
Electronic Resource